Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
about
Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomicsOncoproteomics: Trials and tribulations.Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6.Novel diagnostic cerebrospinal fluid biomarkers for pathologic subtypes of frontotemporal dementia identified by proteomics.Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.Mass spectrometric protein maps for biomarker discovery and clinical research.Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.Quantitative mass spectrometry for colorectal cancer proteomics.Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.Evaluation and Application of Dimethylated Amino Acids as Isobaric Tags for Quantitative Proteomics of the TGF-β/Smad3 Signaling Pathway.Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.Methylcrotonyl-CoA Carboxylase Regulates Triacylglycerol Accumulation in the Model Diatom Phaeodactylum tricornutum.Distribution volumes of macromolecules in human ovarian and endometrial cancers--effects of extracellular matrix structure.Peptide-mediated ‘miniprep’ isolation of extracellular vesicles is suitable for high-throughput proteomics.Venomous Arachnid Diagnostic Assays, Lessons from Past Attempts
P2860
Q34812703-74FFC576-D536-4810-BC7F-9FE18578CC8DQ35827653-ACE7EC98-14F5-45CE-8838-7CD7F7A45EE7Q36021520-9A5AF022-537F-45AD-B25D-C9D8660CEE1CQ36934178-0C740775-61C2-4841-9B02-DE4ED1321D30Q37235596-6C6016F1-0773-4CE1-B90C-F831FC555219Q37324690-D72E395E-CEFB-4854-BC34-8A5D696E77E2Q37714579-79A32786-5FC5-480D-B36F-6EFDE8AF29ADQ38048726-B7FD5EA7-59CD-4CF4-8834-77588DCEE2B9Q38194582-807286D3-2572-43B1-A0D0-404B53C8DB9DQ38753775-280E9031-32FE-4F13-A16A-B2912FFE4ABEQ39560760-83528850-72E2-44B6-94CA-E7AAFE7898E8Q42775329-BDF2036D-64D5-41A9-B226-20FCB3E621DDQ43729457-A7F00AEA-C061-4F6F-A112-4CF9A164168CQ48254850-ACEAB526-5792-4C16-9EBB-1583FA4F774DQ55093040-01E7CF44-42AA-4C8F-A70B-F15D8D4A6158Q57159218-EE65F1EB-A5E5-411E-8730-AFA2C98609F9
P2860
Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
@en
type
label
Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
@en
prefLabel
Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
@en
P2093
P2860
P356
P1476
Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
@en
P2093
Connie R Jimenez
Gideon Oudgenoeg
Sander R Piersma
Thang V Pham
P2860
P304
P356
10.1586/ERM.12.31
P577
2012-05-01T00:00:00Z